Efficacy of Daratumumab-Based Regimens in Anti-CD38 Treatment-Naïve Relapsed/Refractory Multiple Myeloma with High-Risk CytogeneticsJordan Snyder,Razan Mansour, Aytaj Mammadzadeh,Hamza Hashmi,Aimaz Afrough,Omar Alkharabsheh,Barry Paul,Shebli Atrash,Muhammad Umair Mushtaq,Barry S. Skikne,Nausheen Ahmed,Al-Ola AbdallahBlood(2023)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要